GC Wealth Management RIA’s Biogen BIIB Stock Holding History

GC Wealth Management RIA’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,000	Closed	-$280K	–	552
2025 Q3	$280K	Buy	+2,000	New	+$270K	0.01%	727

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GC Wealth Management RIA's BIIB Position: Q4 2025 in Review

GC Wealth Management RIA sold out of Biogen (BIIB) in Q4 2025, closing a stake of 2,000 shares — an estimated $280K sold.

GC Wealth Management RIA first reported a position in BIIB in Q3 2025 and held it in 1 quarter. The position peaked at $280K in Q3 2025. 1,000 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

GC Wealth Management RIA reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
GC Wealth Management RIA sold 2,000 Biogen shares in Q4 2025, an estimated $280K.
GC Wealth Management RIA first reported a position in Biogen in Q3 2025 and held it in 1 quarter.
GC Wealth Management RIA's Biogen position peaked at $280K in Q3 2025.
1,000 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on GC Wealth Management RIA's 13F filing for Q4 2025, filed 30 Jan 2026.